NCT04880343 is a NA clinical trial of Group (A) in Lower Urinary Tract Infection, sponsored by Carmen Gonzalez Enguita.

Who is sponsoring NCT04880343?

NCT04880343 is sponsored by Carmen Gonzalez Enguita.

What drugs are being tested in NCT04880343?

Interventions in NCT04880343: Group (A), Group (B).

What condition does NCT04880343 study?

NCT04880343 studies Lower Urinary Tract Infection.

Is NCT04880343 still recruiting?

NCT04880343 is currently suspended. Last updated 29 September 2023.

Last reviewed 2023-09-29 · How we verify

NCT04880343

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study to Evaluate the Efficacy of the Dietary Supplement UROMANNOSA® in Women With Recurrent Lower Urinary Tract Infections

Suspended NA Last updated 29 September 2023

What this trial tests

NA trial testing Group (A) in Lower Urinary Tract Infection in 108 participants. Suspended.

Timeline

26 January 2021

Primary endpoint
26 January 2024

26 January 2024

Quick facts

Lead sponsor	Carmen Gonzalez Enguita
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	108
Start date	26 January 2021
Primary completion	26 January 2024
Estimated completion	26 January 2024
Sites	1 location across Spain

Drugs / interventions tested

Group (A)
Group (B)

Conditions studied

Lower Urinary Tract Infection — all drugs for Lower Urinary Tract Infection →

Sponsor

Carmen Gonzalez Enguita

Who can join

Adults 18 to 80, female only, with Lower Urinary Tract Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To analyze the clinical impact of a food supplement composed of D Mannose, cranberry extract (Cran-max) and Vitamin D3 in the prevention of recurrent lower urinary tract infections (UTI)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04880343 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carmen Gonzalez Enguita
Last refreshed: 29 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04880343.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing